BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6783626)

  • 21. Physicochemical properties of pyocin F1.
    Kuroda K; Kageyama M; Maeda T; Fujime S
    J Biochem; 1979 Jan; 85(1):21-8. PubMed ID: 104987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents.
    Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z
    Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa.
    McCaughey LC; Josts I; Grinter R; White P; Byron O; Tucker NP; Matthews JM; Kleanthous C; Whitchurch CB; Walker D
    Biochem J; 2016 Aug; 473(15):2345-58. PubMed ID: 27252387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Colicin M-Type Bacteriocin from Pseudomonas aeruginosa Targeting the HxuC Heme Receptor Requires a Novel Immunity Partner.
    Ghequire MGK; Öztürk B
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action.
    Morse SA; Jones BV; Lysko PG
    Antimicrob Agents Chemother; 1980 Sep; 18(3):416-23. PubMed ID: 6775595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple photometric method for determination of the activity of pyrocin R1.
    Kumazaki T; Ishii S
    J Biochem; 1982 Mar; 91(3):817-23. PubMed ID: 6804454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA Damage-Inducible Pyocin Expression Is Independent of RecA in
    Bronson AS; Baggett NS; Cabeen MT
    Microbiol Spectr; 2022 Aug; 10(4):e0116722. PubMed ID: 35708338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structures of the Ultra-High-Affinity Protein-Protein Complexes of Pyocins S2 and AP41 and Their Cognate Immunity Proteins from Pseudomonas aeruginosa.
    Joshi A; Grinter R; Josts I; Chen S; Wojdyla JA; Lowe ED; Kaminska R; Sharp C; McCaughey L; Roszak AW; Cogdell RJ; Byron O; Walker D; Kleanthous C
    J Mol Biol; 2015 Aug; 427(17):2852-66. PubMed ID: 26215615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage.
    Nakayama K; Takashima K; Ishihara H; Shinomiya T; Kageyama M; Kanaya S; Ohnishi M; Murata T; Mori H; Hayashi T
    Mol Microbiol; 2000 Oct; 38(2):213-31. PubMed ID: 11069649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pyocin types and proteolytic properties of Pseudomonas pyocyanea organisms in burned patients and in the milieu of the Division of Burns, Institute of Hematology in Warsaw].
    Bukowska D; Serafińska D; Nasilowski W; Zietkiewicz W
    Pol Tyg Lek; 1976 Jun; 31(26):1107-10. PubMed ID: 821048
    [No Abstract]   [Full Text] [Related]  

  • 34. SOS-Independent Pyocin Production in P. aeruginosa Is Induced by XerC Recombinase Deficiency.
    Baggett NS; Bronson AS; Cabeen MT
    mBio; 2021 Dec; 12(6):e0289321. PubMed ID: 34809462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope.
    Uratani Y
    J Bacteriol; 1982 Feb; 149(2):523-8. PubMed ID: 6799489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical relationship among three F-type pyocins, pyocin F1, F2, and F3, and phage KF1.
    Kuroda K; Kagiyama R
    J Biochem; 1983 Nov; 94(5):1429-41. PubMed ID: 6654864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on fibers isolated from four R-type pyocins, phage-tail-like bacteriocins of Pseudomonas aeruginosa.
    Kumazaki T; Ishii S
    J Biochem; 1982 Nov; 92(5):1559-66. PubMed ID: 6818225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
    Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
    Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between pyocin-sensitivity and 2-amino sugar composition of Pseudomonas aeruginosa.
    Suzuki N
    FEBS Lett; 1974 Nov; 48(2):301-5. PubMed ID: 4215680
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pyocin production by bacillus pyocyaneus and sensitivity of strains of different origin to them].
    Kurnosova LM; Sukhodol'skaia AE; Suvorova TI; Faustova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):8-13. PubMed ID: 6776722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.